Bio-Techne Total Revenue

The latest total revenue for TECH is $1.2B as of March 2026. That compares with $1.2B in the prior-year period — up 0.2% year over year. That is below the Healthcare sector average of $110B. Investors often review this figure alongside Bio-Techne's historical trend and sector peers before judging valuation or financial health.

Over the past year, TECH's total revenue moved from $1.2B to $1.2B — a 0.2% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Bio-Techne's operating scale or balance-sheet position.

Against Healthcare companies, TECH currently prints $1.2B for total revenue, while the sector average sits near $110B. That is roughly 98.9% below the sector mean. Large gaps often invite a closer look at Bio-Techne's growth, margins, and balance sheet.

A total revenue figure of $1.2B for TECH is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $110B. Explore the charts below for those layers of context.

After noting TECH's total revenue ($1.2B), review year-over-year change from $1.2B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.